Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

Despite the need for novel, effective therapeutics for the COVID-19 pandemic, no curative regimen is yet available, therefore patients are forced to rely on supportive and nonspecific therapies. Some SARS-CoV-2 proteins, like the 3 C-like protease (3CLpro) or the major protease (Mpro), have been ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemian, Seyed Mohammad Reza, Sheida, Amirhossein, Taghizadieh, Mohammad, Memar, Mohammad Yousef, Hamblin, Michael R., Bannazadeh Baghi, Hossein, Sadri Nahand, Javid, Asemi, Zatollah, Mirzaei, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899776/
https://www.ncbi.nlm.nih.gov/pubmed/37018987
http://dx.doi.org/10.1016/j.biopha.2023.114367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899776/
https://www.ncbi.nlm.nih.gov/pubmed/37018987
http://dx.doi.org/10.1016/j.biopha.2023.114367

Ejemplares similares